0326 GMT - Frencken Group's revenue is set to improve in 2026 as it remains a key beneficiary of the recovery in the semiconductor industry, Maybank Securities' Jarick Seet says in a note. In addition, he says the Singapore-listed technology services provider's revenue for its analytical and life sciences segment should have bottomed in 1Q. Maybank expects the segment's revenue to increase in the coming quarters thanks to the planned introduction of new products. Maybank maintains a buy rating on the stock and its target price of 3.40 Singapore dollars. Shares are 4.3% higher at S$2.93. (amanda.lee@wsj.com)
(END) Dow Jones Newswires
May 19, 2026 23:26 ET (03:26 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.